We are live on ! Find out more
BA

BlackRock Advisors Portfolio holdings

AUM $98.8B
1-Year Est. Return 15.8%
This Fund
S&P 500
This Quarter Est. Return
-7.26%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$93.3B
AUM Growth
-$2.89B
Cap. Flow
+$5.74B
Cap. Flow %
6.15%
Top 10 Hldgs %
15.28%
Holding
3,878
New
163
Increased
1,568
Reduced
1,679
Closed
111

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$423M
2
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$367M
3
XOM icon
ExxonMobil
XOM
+$337M
4
JNJ icon
Johnson & Johnson
JNJ
+$257M
5
BIIB icon
Biogen
BIIB
+$250M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$195M
2
ABBV icon
AbbVie
ABBV
+$188M
3
JPM icon
JPMorgan Chase
JPM
+$183M
4
BMY icon
Bristol-Myers Squibb
BMY
+$176M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$174M

Sector Composition

Rank Sector Weight
1 Healthcare 18.49%
2 Financials 16.75%
3 Technology 9.99%
4 Industrials 8.32%
5 Energy 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RDS.A
276
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$58M 0.06%
1,224,659
-1,689,638
-58% -$90.6M
CPN
277
DELISTED
Calpine Corporation
CPN
$57.3M 0.06%
3,922,229
+239,467
+7% +$3.93M
ADBE icon
278
Adobe
ADBE
$89.5B
$56.3M 0.06%
684,479
+134,699
+25% +$10.9M
ADM icon
279
Archer Daniels Midland
ADM
$41.4B
$56M 0.06%
1,351,456
+160,770
+14% +$7.34M
HAL icon
280
Halliburton
HAL
$27.9B
$55.6M 0.06%
1,573,385
+397,904
+34% +$15.7M
RARE icon
281
Ultragenyx Pharmaceutical
RARE
$2.65B
$55.3M 0.06%
574,214
+108,177
+23% +$12.4M
DST
282
DELISTED
DST Systems Inc.
DST
$54.9M 0.06%
1,045,156
+271,512
+35% +$15.1M
UN
283
DELISTED
Unilever NV New York Registry Shares
UN
$54.6M 0.06%
1,358,687
-84,577
-6% -$3.56M
CYH icon
284
Community Health Systems
CYH
$385M
$54.5M 0.06%
1,542,423
-136,837
-8% -$6.27M
EPC icon
285
Edgewell Personal Care
EPC
$1.27B
$54.4M 0.06%
666,527
+612,855
+1,142% +$55.5M
XEC
286
DELISTED
CIMAREX ENERGY CO
XEC
$54M 0.06%
527,243
+50,514
+11% +$5.38M
CERN
287
DELISTED
Cerner Corp
CERN
$53.9M 0.06%
899,141
+392,710
+78% +$25.7M
BCR
288
DELISTED
CR Bard Inc.
BCR
$53.7M 0.06%
288,223
+95,650
+50% +$18.1M
FIS icon
289
Fidelity National Information Services
FIS
$21.5B
$52.8M 0.06%
787,021
+159,135
+25% +$10.6M
INCY icon
290
Incyte
INCY
$23.5B
$52.2M 0.06%
473,055
-203,579
-30% -$22.8M
NVDA icon
291
NVIDIA
NVDA
$5.01T
$52M 0.06%
84,317,760
+27,253,960
+48% +$14.7M
TER icon
292
Teradyne
TER
$54.8B
$52M 0.06%
2,884,765
+15,693
+0.5% +$289K
TJX icon
293
TJX Companies
TJX
$170B
$51.3M 0.06%
1,435,732
+865,992
+152% +$30.4M
MDVN
294
DELISTED
MEDIVATION, INC.
MDVN
$51.2M 0.05%
1,205,349
+225,053
+23% +$11.1M
AZN icon
295
AstraZeneca
AZN
$263B
$51M 0.05%
801,478
-572,668
-42% -$37.7M
SPN
296
DELISTED
Superior Energy Services, Inc.
SPN
$51M 0.05%
403,812
+92,911
+30% +$15.2M
HES
297
DELISTED
Hess
HES
$50.6M 0.05%
1,011,600
+299,253
+42% +$17.1M
ZBH icon
298
Zimmer Biomet
ZBH
$17.7B
$50.2M 0.05%
550,390
+188,917
+52% +$18.9M
PSX icon
299
Phillips 66
PSX
$82.9B
$48.8M 0.05%
635,646
-1,863,577
-75% -$148M
FMC icon
300
FMC
FMC
$1.42B
$48.4M 0.05%
1,645,371
+174,541
+12% +$6.76M
10 11
12
13 14

Similar funds

BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
BJ
BlackRock Japan Tokyo, Japan $30.3B AUM 13.85% 1-Year Est. Return
IC
Institutional Capital Chicago, Illinois $6.75B AUM 3.44% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
MFS
MSI Financial Services Springfield, Massachusetts $3.07B AUM 10.22% 1-Year Est. Return
CIM
Calvert Investment Management Bethesda, Maryland $2.67B AUM 16.23% 1-Year Est. Return
KAM
Keeley Asset Management Chicago, Illinois $2.35B AUM 26.92% 1-Year Est. Return
PFM
PacWest Financial Management Phoenix, Arizona $1.69B AUM 8.84% 1-Year Est. Return

BlackRock Advisors's Q3 2015 Portfolio in Review

As of Q3 2015, BlackRock Advisors held 3,878 positions worth $93.3B, down 3% from $96.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

BlackRock Advisors deployed $5.74B of net new capital in Q3 2015, opening 163 new positions and adding to 1,568 existing holdings. Its largest new stake was Allergan plc: 186,940 shares worth $176M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $195M trimmed.

  • BlackRock Advisors's largest Q3 2015 buy was Allergan plc: 186,940 shares worth $176M.
  • BlackRock Advisors added most to Apple in Q3 2015, an estimated $423M increase.
  • BlackRock Advisors's biggest Q3 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $195M.
  • BlackRock Advisors fully exited RECEPTOS INC COM STK (DE) in Q3 2015, selling an estimated $108M.
  • BlackRock Advisors's ten largest holdings make up 15% of its $93.3B portfolio in Q3 2015.
  • BlackRock Advisors opened 163 new positions and closed 111 in Q3 2015.
  • BlackRock Advisors's portfolio value fell 3% quarter-over-quarter to $93.3B.

Based on BlackRock Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.